Elevated testosterone can contribute to hair loss in some women, but most women with female pattern hair loss do not have abnormally high testosterone levels.
Female pattern hair loss develops through a complex interaction between genetics, age, follicle sensitivity, hormones and other health factors. Some women have biochemical androgen excess. Others have normal blood results but hair follicles that remain sensitive to androgen signalling.
Therefore, a widening part or reduced crown density should not automatically be diagnosed as “high testosterone.” The pattern must be distinguished from telogen effluvium, thyroid-related shedding, nutritional deficiency, medication effects, alopecia areata and inflammatory or scarring alopecia.
This guide explains how testosterone may affect female hair follicles, which symptoms suggest androgen excess, common and uncommon causes, how testing is performed and when rapidly developing symptoms require urgent medical evaluation.
Medical note: Hormone testing and diagnosis should be managed by a doctor, endocrinologist, gynaecologist or another appropriately licensed healthcare professional. A trichologist can assess the visible hair-loss pattern and identify signs that need medical referral.
Key Takeaways
- Female pattern hair loss does not automatically mean high testosterone. Most affected women have circulating androgen levels within their laboratory’s reference range.
- Follicle sensitivity matters. Hair follicles may respond to androgen signalling even when blood testosterone is not elevated.
- PCOS is the most common cause of androgen excess in reproductive-age women. Possible clues include irregular cycles, hirsutism, acne, infertility and insulin resistance.
- No single testosterone cutoff applies to everyone. Interpretation depends on the assay, laboratory, age, menopausal status, medication and clinical presentation.
- Assay quality matters. Liquid chromatography–tandem mass spectrometry is preferred for measuring the relatively low testosterone concentrations found in women.
- Rapid progression is a warning sign. Sudden hirsutism, voice deepening, clitoral enlargement, increased muscularity or rapid scalp hair loss requires prompt medical investigation.
- Severe androgen excess has several possible causes. These include ovarian hyperthecosis, androgen-secreting ovarian or adrenal tumours, non-classic congenital adrenal hyperplasia and severe insulin-resistance syndromes.
- Treatment must address both the diagnosis and the hair. Correcting an endocrine disorder does not always reverse established follicular miniaturisation, so diagnosis-specific hair treatment may also be needed.
Hair Loss With Hormonal Symptoms?
A widening part together with irregular periods, new facial hair, persistent acne or fertility problems may justify medical hormone assessment.
A trichologist can examine the scalp and hair-loss pattern. Hormone diagnosis, laboratory interpretation and treatment should remain with an appropriately licensed medical professional.
Looking for Someone Local?
Quick Next Steps
- Identify the hair-loss pattern: A widening central part, diffuse shedding, recession, bald patches and breakage have different causes.
- Review other androgen-related symptoms: Note new facial or body hair, acne, irregular cycles, fertility concerns and changes in voice or muscle mass.
- Build a timeline: Record when symptoms started, how quickly they progressed and whether they followed pregnancy, menopause, medication or supplement changes.
- List every exposure: Include prescribed hormones, testosterone gels used by a partner, anabolic steroids, supplements and compounded products.
- Do not interpret one result alone: Testosterone should be assessed against the correct laboratory range and the broader clinical picture.
- Seek prompt care for virilisation: Voice deepening, clitoral enlargement or rapidly progressing symptoms need timely medical investigation.
How Testosterone Can Affect Hair in Women
Testosterone is an androgen hormone present in both women and men. In women, androgens are produced by the ovaries and adrenal glands. They are also generated through conversion of precursor hormones in other tissues.
Within susceptible scalp follicles, testosterone can be converted to dihydrotestosterone, or DHT, by 5-alpha-reductase enzymes.
Androgen signalling may contribute to:
- Progressive follicular miniaturisation
- Shorter periods of active growth
- Production of finer and shorter hairs
- Reduced visible density over time
However, the role of androgens in female pattern hair loss is less direct and consistent than it is in male pattern hair loss.
Most women with female pattern hair loss have normal circulating testosterone and no other clinical signs of androgen excess. Consequently, blood hormone concentration is only one part of the assessment.
Learn more about female pattern hair loss.
What Female Pattern Hair Loss Looks Like
Female pattern hair loss usually causes gradual loss of density rather than sudden complete baldness.
Common patterns include:
- Widening of the central part
- Reduced density over the crown or mid-scalp
- A “Christmas tree” pattern that is more visible toward the frontal scalp
- Progressive production of finer hairs
- Retention of the frontal hairline in many women
A more male-pattern distribution, with marked temple recession or frontotemporal loss, may raise additional questions about androgen activity. However, pattern alone still cannot establish a hormone diagnosis.
Hair Loss Alone Does Not Prove Hyperandrogenism
Hyperandrogenism means that a woman has clinical signs of excessive androgen effect, biochemical elevation on appropriate testing or both.
Clinical hyperandrogenism may include:
- Hirsutism, meaning coarse terminal hair in an androgen-dependent distribution
- Persistent or severe acne
- Female pattern hair loss in the appropriate context
- Signs of virilisation in more severe cases
Isolated scalp thinning with normal androgen levels and no other symptoms should not automatically be described as an androgen-excess disorder.
Hair loss may also result from:
- Telogen effluvium
- Iron deficiency
- Thyroid disease
- Illness or surgery
- Rapid weight loss
- Medication changes
- Alopecia areata
- Traction
- Scarring alopecia
- Hair-shaft breakage
Symptoms That Make Androgen Testing More Relevant
Medical hormone assessment becomes more relevant when hair loss occurs with other features such as:
- New or increasing coarse facial or body hair
- Irregular, infrequent or absent menstrual periods
- Difficulty conceiving
- Persistent inflammatory acne
- Darkened, thickened skin associated with insulin resistance
- Unexplained changes in weight or metabolic health
- Rapidly progressive pattern hair loss
- Symptoms beginning after testosterone, androgen or steroid exposure
- New androgenic symptoms after menopause
Urgent Warning Signs
Rapidly developing virilisation is different from gradual pattern hair loss.
Seek prompt medical evaluation for:
- Sudden or rapidly worsening hirsutism
- Deepening of the voice
- Clitoral enlargement
- Rapid increase in muscularity
- Reduced breast tissue
- Rapidly progressive scalp hair loss
- New severe acne with other virilising changes
- Symptoms progressing over a few months rather than several years
These findings do not prove cancer. However, they can occur with severe ovarian or adrenal androgen excess and should not be managed only as a cosmetic hair concern.
Important: rapidly progressive virilisation, especially after menopause, requires prompt assessment by a doctor or endocrinologist. Do not wait for a routine hair-product trial to finish.
What Is a Normal Testosterone Level for Women?
There is no single universal number that defines normal testosterone for every woman.
Interpretation depends on:
- Age
- Premenopausal or postmenopausal status
- Time of sample collection
- Menstrual-cycle context
- Pregnancy status
- Hormonal contraception
- Hormone-replacement therapy
- Other medication
- Sex hormone-binding globulin concentration
- Testing method
- The laboratory’s validated reference interval
Female testosterone concentrations are much lower than typical male concentrations. Some routine immunoassays are less accurate at these lower levels.
Current guidelines prefer a reliable assay, ideally liquid chromatography–tandem mass spectrometry, when accurate quantification is important.
Total Testosterone
Total testosterone measures both protein-bound and unbound hormone in the blood.
It is often the first androgen measurement. However, total testosterone may not reflect the amount available to tissues when sex hormone-binding globulin is unusually high or low.
Free Testosterone and Free Androgen Index
Only a small proportion of testosterone circulates unbound.
Reliable assessment may involve:
- A validated direct or equilibrium method
- Calculated free testosterone
- Total testosterone interpreted with sex hormone-binding globulin
- A free androgen index in an appropriate clinical setting
Not all direct free-testosterone tests are equally reliable. A clinician should interpret the method used by the laboratory.
DHEAS and Androstenedione
DHEAS is produced mainly by the adrenal glands. A markedly elevated result can direct attention toward an adrenal source, although no single result should be interpreted without context.
Androstenedione may provide additional information when testosterone results do not fully explain the clinical presentation.
When Is a Testosterone Result Considered Concerning?
The degree of elevation, assay method and clinical presentation all matter.
The 2025 Society for Endocrinology guideline recommends further investigation when testosterone concentrations exceed the laboratory’s female reference range. It identifies a concentration above approximately 5 nmol/L as an important threshold for prompt confirmation and investigation for severe androgen excess.
This does not mean that:
- Every result below 5 nmol/L is harmless
- Every result above 5 nmol/L proves a tumour
- The threshold can be applied to an unconfirmed result from any assay
- Symptoms and menopausal status can be ignored
Unexpected or severe results should usually be confirmed using a high-quality method before major diagnostic decisions are made.
Common Causes of Elevated Testosterone in Women
| Cause | Typical Context | Important Point |
|---|---|---|
| Polycystic ovary syndrome | Irregular ovulation, hirsutism, acne, fertility concerns or metabolic features | The most common cause of androgen excess in reproductive-age women |
| Medication or external androgen exposure | Testosterone therapy, anabolic steroids, androgenic supplements or transfer from another person’s topical testosterone | A complete exposure history is essential |
| Ovarian hyperthecosis | More often considered in postmenopausal women with significant androgen excess | Can cause virilisation and may require specialist investigation |
| Non-classic congenital adrenal hyperplasia | Hirsutism, acne, menstrual disturbance or relevant family and ethnic background | Early-morning 17-hydroxyprogesterone is commonly used for screening |
| Androgen-secreting ovarian or adrenal tumour | Rapid symptom progression, virilisation or severe biochemical elevation | Rare but important to exclude promptly |
| Cushing syndrome | Specific features of cortisol excess alongside possible androgen symptoms | Testing should be driven by the broader clinical picture |
| Severe insulin-resistance syndromes | Marked insulin resistance, acanthosis nigricans or severe metabolic features | Specialist endocrine assessment may be required |
Polycystic Ovary Syndrome
PCOS is the most common cause of androgen excess in women of reproductive age.
Possible features include:
- Irregular or absent ovulation
- Infrequent or unpredictable periods
- Hirsutism
- Acne
- Female pattern hair loss
- Difficulty conceiving
- Insulin resistance
- Metabolic risk factors
PCOS cannot be diagnosed from hair loss, one testosterone result or an ultrasound alone.
Diagnosis uses established criteria after excluding relevant alternative causes. The precise approach differs for adults and adolescents.
In adults, polycystic ovarian morphology on ultrasound may contribute to diagnosis in some circumstances. However, ultrasound is not always required when ovulatory dysfunction and hyperandrogenism are already established.
Medication and External Androgen Exposure
Medication and supplement history can reveal an avoidable cause.
Relevant exposures may include:
- Prescribed testosterone
- Compounded hormone products
- Anabolic-androgenic steroids
- Dehydroepiandrosterone supplements
- Products marketed for bodybuilding or sexual performance
- Selected progestins with androgenic activity
- Valproate in an appropriate clinical context
Secondary exposure can occur when a household member uses topical testosterone gel and treated skin contacts another person before the product has dried or been covered as directed.
Do not stop prescribed medication without speaking to the prescriber.
Ovarian Hyperthecosis
Ovarian hyperthecosis involves androgen-producing cells within the ovaries. It is particularly relevant in postmenopausal women with substantial biochemical androgen excess or virilisation.
Symptoms may progress more gradually than symptoms caused by some androgen-secreting tumours. Nevertheless, specialist assessment is needed.
Androgen-Secreting Ovarian or Adrenal Tumours
Androgen-secreting tumours are uncommon. Most women with androgen-related symptoms do not have cancer.
Concern rises when there is:
- Rapid onset or progression
- Clear virilisation
- Severe testosterone elevation
- Marked adrenal androgen elevation
- New androgen excess after menopause
- A pelvic or adrenal mass
A high testosterone result cannot reliably determine whether the source is ovarian or adrenal by itself. DHEAS, androstenedione, clinical findings and targeted imaging may help guide investigation.
Conditions That Can Resemble Androgen Excess
Some conditions cause overlapping symptoms without being direct common causes of elevated testosterone.
Thyroid Disease
Thyroid disease can cause menstrual changes and diffuse shedding. It may also influence sex hormone-binding globulin.
However, hyperthyroidism should not be listed as a routine direct cause of marked testosterone excess.
Hyperprolactinaemia
Elevated prolactin can cause irregular periods, infertility or galactorrhoea. It can enter the differential diagnosis when those symptoms are present.
A prolactinoma is not a standard direct cause of severe testosterone elevation.
Menopause
After menopause, oestrogen declines more sharply than androgen production. This can change the relative androgen environment even when testosterone is not above the laboratory range.
New, rapidly progressing androgenic symptoms after menopause still need medical evaluation.
How Elevated Testosterone Is Investigated
Testing should be individualised. Not every woman needs every hormone or imaging study.
Medical History
A clinician may ask about:
- Age at symptom onset
- Rate of progression
- Menstrual-cycle pattern
- Pregnancy and fertility history
- Menopause
- Acne and hirsutism
- Changes in voice, muscle mass or genital anatomy
- Weight and metabolic changes
- Medication, hormone and supplement exposure
- Family history
- Hair-loss pattern and duration
Physical and Scalp Examination
Examination may assess:
- Distribution and severity of hirsutism
- Acne
- Signs of virilisation
- Acanthosis nigricans
- Cushingoid features when clinically suspected
- Female pattern hair-loss distribution
- Follicular miniaturisation on trichoscopy
- Signs of inflammation or scarring
Possible Blood Tests
Depending on the presentation, medical testing may include:
- Total testosterone using a reliable assay
- Sex hormone-binding globulin
- An estimate or measurement of free testosterone
- DHEAS
- Androstenedione
- Early-morning 17-hydroxyprogesterone
- LH and FSH in selected contexts
- Oestradiol in selected contexts
- Prolactin when symptoms justify it
- TSH when thyroid disease is possible
- Pregnancy testing where relevant
- Cortisol-related testing when Cushing syndrome is suspected
- Metabolic screening when PCOS or insulin resistance is possible
AFP and beta-hCG are not universal routine androgen tests. Tumour markers or other specialised testing should be ordered only when the clinical investigation justifies them.
Timing and Accuracy of Testosterone Testing
Where clinically appropriate, blood is often collected in the morning because of hormone variation.
For premenopausal women with regular cycles, some investigations may be timed to the early follicular phase. However, this is not practical or required in every situation.
Hormonal contraceptives can make biochemical androgen assessment difficult by changing sex hormone-binding globulin and ovarian androgen production.
The 2023 PCOS guideline notes that if biochemical testing is essential while someone takes a combined oral contraceptive, a clinician may consider withdrawal for at least three months with alternative contraception. This decision must be medically supervised. Patients should not stop contraception solely to obtain a hair-loss blood test.
Why a Result May Need Repeating
Repeat or confirmatory testing may be appropriate when:
- The result does not match the clinical presentation
- The value is unexpectedly high
- The laboratory used a less reliable method
- Medication or supplement interference is possible
- Sample timing or handling may have affected the result
When Is Imaging Needed?
Imaging is not automatically required for every woman with hair loss or mild testosterone elevation.
Depending on symptoms and confirmed laboratory findings, a doctor may consider:
- Pelvic ultrasound
- Pelvic magnetic resonance imaging
- Adrenal computed tomography
- Adrenal magnetic resonance imaging
The choice depends on whether the likely source appears ovarian or adrenal, how severe the androgen excess is and whether symptoms are progressing rapidly.
How Hormone-Related Hair Loss Is Treated
Treatment has two connected goals:
- Identify and manage the cause of androgen excess.
- Protect or stimulate scalp follicles when appropriate.
Treating the Underlying Condition
Management may involve:
- PCOS-directed care
- Reviewing an androgenic medication or supplement
- Treatment of non-classic congenital adrenal hyperplasia when indicated
- Management of metabolic risk and insulin resistance
- Specialist treatment of ovarian hyperthecosis
- Surgical or oncology assessment for an androgen-secreting tumour
Topical Minoxidil
Topical minoxidil is the best-established first-line treatment for female pattern hair loss.
It may cause temporary early shedding, scalp irritation or unwanted facial hair. Continued treatment is normally required to maintain benefit.
Learn more about minoxidil for hair loss.
Anti-Androgen Treatment
A licensed prescriber may consider an anti-androgen for selected women, particularly when pattern hair loss occurs with clinical or biochemical hyperandrogenism.
Options used in specialist practice may include spironolactone or selected 5-alpha-reductase inhibitors. Suitability depends on age, pregnancy potential, medical history, blood pressure, kidney function, medication and local prescribing rules.
Some anti-androgen medicines can harm a developing male fetus. Reliable contraception may be required when pregnancy is possible.
Do not buy or combine hormonal treatments without medical supervision.
Hair Transplantation and Procedural Options
Hair transplantation may be considered when the diagnosis is stable, donor density is adequate and medical contributors have been addressed.
Low-level laser therapy and platelet-rich plasma are also used by some clinicians. Evidence and response vary, and neither replaces investigation of significant androgen excess.
Will Hair Grow Back After Testosterone Is Controlled?
Improvement depends on the cause, duration and degree of follicular miniaturisation.
Reducing excessive androgen exposure may slow further progression. However, hormone correction does not guarantee complete regrowth, particularly when thinning has been present for years.
Hair follicles change slowly. Objective assessment usually requires:
- Baseline scalp photographs
- Consistent lighting and hairstyle
- Trichoscopic measurements when available
- Several months of follow-up
- Monitoring of both shedding and density
Scarring hair loss requires a different approach because destroyed follicles cannot regenerate.
Who Should Coordinate Care?
| Professional | Possible Role |
|---|---|
| Trichologist | Scalp and hair assessment, history review, photographic monitoring and identification of medical referral signs |
| Dermatologist | Medical hair-loss diagnosis, trichoscopy, biopsy when required and prescription treatment |
| Endocrinologist | Assessment of severe or complex androgen excess, adrenal and ovarian sources and endocrine testing |
| Gynaecologist | Menstrual, ovarian, fertility and menopausal assessment |
| Primary-care doctor | Initial medical evaluation, targeted testing and coordination of specialist referral |
Get the Hair-Loss Pattern Assessed
Hormones are only one possible part of female hair loss. A scalp assessment can help distinguish pattern thinning from diffuse shedding, inflammation, breakage and other conditions.
Frequently Asked Questions
- Can high testosterone cause hair loss in women?
- Yes. Significant androgen excess can contribute to female pattern hair loss in susceptible women. However, most women with female pattern hair loss have testosterone levels within the normal laboratory range.
- Does female pattern hair loss mean I have PCOS?
- No. PCOS is one possible cause when hair loss occurs with irregular ovulation, hirsutism, acne or metabolic features. Hair loss alone cannot diagnose PCOS.
- What testosterone level is too high for a woman?
- Results must be compared with an age-appropriate female reference range from a reliable laboratory. Current endocrine guidance treats a confirmed result around or above 5 nmol/L as an important trigger for prompt investigation, but it is not a universal self-diagnosis cutoff.
- Can I have androgen-related hair loss with normal testosterone?
- Yes. Follicle sensitivity and local androgen metabolism may contribute even when circulating testosterone is within the laboratory range.
- What other symptoms suggest high testosterone?
- Possible signs include hirsutism, severe acne, irregular periods, difficulty conceiving and, in severe cases, voice deepening, clitoral enlargement or rapidly increasing muscularity.
- Can menopause increase testosterone?
- Absolute testosterone does not necessarily rise, but oestrogen may decline more sharply and alter the relative hormonal environment. New or rapidly progressive androgenic symptoms after menopause still require evaluation.
- Should testosterone be tested in the morning?
- Morning sampling is often preferred, particularly when investigating androgen excess. Timing, menstrual status, medication and assay method should be decided by the treating clinician.
- Can birth-control pills affect testosterone test results?
- Yes. Combined hormonal contraception can raise sex hormone-binding globulin and suppress ovarian androgen production, making biochemical assessment difficult. Do not stop contraception without medical guidance.
- Can lowering testosterone regrow hair?
- Managing genuine androgen excess may slow progression and support treatment. Complete regrowth is not guaranteed, especially when follicular miniaturisation is advanced.
- When is elevated testosterone urgent?
- Rapid symptom progression, voice deepening, clitoral enlargement, severe hirsutism, increased muscularity or new virilisation after menopause requires prompt medical investigation.
Conclusion
Elevated testosterone can contribute to hair loss in women, but it is not the explanation for every widening part or thinning crown.
Most women with female pattern hair loss have normal circulating androgen levels. Follicle sensitivity, genetics, age and local hormone metabolism can still influence miniaturisation.
When hair loss occurs alongside hirsutism, acne, irregular periods, fertility problems or metabolic symptoms, medical androgen assessment may be appropriate. PCOS is the most common cause in reproductive-age women.
Rapid virilisation, severe biochemical elevation or new androgen excess after menopause requires prompt investigation for less common ovarian or adrenal causes.
The safest approach combines accurate hair-loss diagnosis, reliable hormone testing when indicated and treatment directed at both the underlying condition and the scalp follicles.
References
Elhassan YS, et al. Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women.
Teede HJ, et al. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Endocrine Society. Hirsutism Guideline Resources.
Carmina E, et al. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
Hirschberg AL. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Ramos PM, Miot HA. Female-Pattern Hair Loss: Therapeutic Update.
British Association of Dermatologists. Female Pattern Hair Loss.
European Society of Human Reproduction and Embryology. International Evidence-Based PCOS Guideline.
Medical disclaimer: This article provides general educational information and does not diagnose elevated testosterone, PCOS, an ovarian or adrenal disorder, or any type of hair loss. Laboratory results, imaging and hormone treatment require interpretation by an appropriately licensed healthcare professional. Seek prompt medical assessment for rapidly progressing symptoms or signs of virilisation.